A detailed history of Bank Of America Corp transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 706,544 shares of IDYA stock, worth $18.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
706,544
Previous 481,600 46.71%
Holding current value
$18.8 Million
Previous $16.9 Million 32.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.37 - $43.05 $6.83 Million - $9.68 Million
224,944 Added 46.71%
706,544 $22.4 Million
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $4.05 Million - $5.12 Million
117,886 Added 32.41%
481,600 $16.9 Million
Q1 2024

May 15, 2024

BUY
$34.2 - $47.13 $5.97 Million - $8.23 Million
174,519 Added 92.24%
363,714 $16 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $2.45 Million - $3.57 Million
99,559 Added 111.07%
189,195 $6.73 Million
Q2 2023

Aug 14, 2023

SELL
$13.33 - $25.53 $1.15 Million - $2.19 Million
-85,910 Reduced 48.94%
89,636 $2.11 Million
Q1 2023

May 12, 2023

BUY
$13.49 - $18.72 $72,980 - $101,275
5,410 Added 3.18%
175,546 $2.41 Million
Q4 2022

Feb 10, 2023

BUY
$14.47 - $18.17 $839,231 - $1.05 Million
57,998 Added 51.72%
170,136 $3.09 Million
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $534,589 - $913,546
57,856 Added 106.58%
112,138 $1.67 Million
Q2 2022

Aug 12, 2022

SELL
$8.28 - $13.88 $921,597 - $1.54 Million
-111,304 Reduced 67.22%
54,282 $749,000
Q1 2022

May 16, 2022

BUY
$11.18 - $24.02 $615,157 - $1.32 Million
55,023 Added 49.77%
165,586 $1.85 Million
Q4 2021

Feb 08, 2022

BUY
$20.95 - $26.88 $2.22 Million - $2.85 Million
105,954 Added 2298.85%
110,563 $2.61 Million
Q3 2021

Nov 15, 2021

SELL
$17.26 - $27.08 $61,618 - $96,675
-3,570 Reduced 43.65%
4,609 $118,000
Q2 2021

Sep 13, 2021

BUY
$17.76 - $24.83 $145,259 - $203,084
8,179 New
8,179 $171,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.28B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.